MCO Molecular and Clinical Oncology 2049-9450 2049-9469 D.A. Spandidos 10.3892/mco.2015.539 MCO-0-0-539 Articles Analysis of mitochondrial DNA in Tibetan gastric cancer patients at high altitude JIANGJUN 1 2 ZHAOJUN-HUI 2 WANGXUE-LIAN 3 DIJI 2 LIUZHI-BO 2 LIGUO-YUAN 2 WANGMIAO-ZHOU 2 LIYAN 2 CHENRONG 2 GERI-LI 1 Research Center for High Altitude Medicine, Qinghai University, Xining, Qinghai 810001, P.R. China Department of Oncology, Affiliated Hospital of Qinghai University, Xining, Qinghai 810001, P.R. China Department of Surgery, Affiliated Hospital of Qinghai University, Xining, Qinghai 810001, P.R. China Correspondence to: Professor Ri-Li Ge or Dr Jun Jiang, Research Center for High Altitude Medicine, Qinghai University, 16 Kun-Lun Road, Chengxi District, Xining, Qinghai 810001, P.R. China, E-mail: gerriligao@hotmail.com, E-mail: xnrheum@126.com 07 2015 03 04 2015 3 4 875 879 20082014 07102014 Copyright © 2015, Spandidos Publications 2015

The highest risk areas of gastric cancer are currently Japan, Korea and China; Qinghai, a high-altitude area, has one of the highest gastric cancer rates in China. The incidence of gastric cancer is higher in the Tibetan ethnic group compared to that in the Han ethnic group in Qinghai. This study was conducted to determine the clinical characteristics of mitochondrial DNA (mtDNA) mutations and copy numbers among Tibetans with gastric cancer residing at high altitudes and investigate the association between adaptations to hypoxic conditions and oncogenesis. A total of 23 Tibetan gastric cancer patients and 40 matched controls were recruited in this study. Leukocyte mtDNA genes and copy numbers were analyzed. The haplogroups were classified based on mitochondrial gene sequences. A total of 56.5% of the study participants had used alcohol at some point in their lives and 73.9% were positive for Helicobacter pylori (H. pylori). Eight mutations in 8 mitochondrial genes were identified in 43.4% of the Tibetan cancer patient group. There were no significant differences in leukocyte mtDNA copy number levels based on smoking status, alchohol consumption, obesity or H. pylori infection between the control and cancer groups. Statistical differences were also not found between gastric cancer patients with and those without mtDNA mutations. The majority of Tibetan patients with gastric cancer belonged to the mitochondrial haplogroup M9. In conclusion, Tibetans with gastric cancer residing at high altitudes exhibited a wide spectrum of mtDNA mutations. However, leukocyte mtDNA copy numbers in stage II gastric cancer were not statistically different compared to those in healthy Tibetans.

 gastric cancer mtDNA copy number Tibetan hypoxia Introduction

Despite a sharp decline in the incidence and mortality rates of gastric cancer, this condition remains the second leading cause of cancer-related mortality worldwide, following lung cancer. Gastric cancer is frequently diagnosed at an advanced stage. The 5-year survival rate is ~20% in developing countries (1). There is a wide variation in the incidence of gastric cancer in different geographical regions. The highest risk areas with an age-standardized incidence rate are Japan, Korea and China (2). The distribution of gastric cancer is not uniform across China. In particular, gastric cancer is the leading type of cancer in Qinghai, a high-altitude area in Northwest China. Moreover, the Chinese National Cancer Center in 2012 reported that Qinghai has one of the highest rates of gastric cancer in China. The incidence of gastric cancer is higher in the Tibetan compared to that in the Han ethnic group in Qinghai, a finding that has attracted significant attention over the last few years.

The marked variation of gastric cancer risk in different geographical areas and the striking differences in potential environmental risk factors between regions prompted the investigation of gastric cancer etiology. Mitochondria are semi-autonomous organelles within cells that play an essential role in cellular energy metabolism, generation of reactive oxygen species (ROS) and apoptosis. The mitochondrial DNA (mtDNA) codes for 37 genes essential to the oxidative phosphorylation system and is present in thousands of copies per cell. In humans, severe mtDNA mutations result in multisystem diseases, whereas certain functional population-specific polymorphisms appear to have enabled humans to adapt to new environments. The copy number and mutations of mtDNA have been found to contribute to the initiation and progression of gastric cancer (3). Hypoxia is one of the most prominent environmental factors at high altitudes. Tibetan individuals inhabiting high-altitude regions exhibit adaptations that enable them to acclimatize to a hypoxic and cold environment; they also exhibit a higher incidence of gastric cancer. The association of gastric cancer with adaptations to a hypoxic and cold environment remains unclear. This study aimed to determine the mtDNA characteristics of Tibetan patients with gastric cancer and investigate the role of mitochondria in gastric cancer under hypoxic conditions.

 Materials and methods <sec> <title>Patients

A total of 23 Tibetan patients with gastric cancer were recruited in this study. All the patients were admitted to the Affiliated Hospital of Qinghai University and diagnosed according to standard clinical and pathological criteria within the 30 months preceding the initiation of the study. The patients were diagnosed with stage II gastric cancer according to the approved international standards described by the American Joint Committee on Cancer Cancer Staging Manual (4). A total of 40 Tibetans were randomly selected among healthy volunteers who were free of cancer and donated a blood sample. The control subjects were individually matched to the gastric cancer patients with respect to age, body mass index, educational level and Helicobacter pylori (H. pylori) infection.

This study was approved by the Ethics Committee of the Affiliated Hospital of Qinghai University and conformed to the tenets of the Helsinki Declaration. All the patients provided written informed consent prior to their inclusion in this study.

 Mitochondrial gene sequence analysis and haplogroup classification

Mitochondrial gene sequence analysis was performed on all the participants. Total DNA was extracted from blood samples by conventional salting-out protocols. The entire mitochondrial genome was amplified by polymerase chain reaction (PCR) into 8 overlapping fragments using sets of light- and heavy-strand oligonucleotide primers. Each fragment was purified and analyzed by direct sequencing. The sequence results were then compared with the revised Cambridge reference sequence (http://www.mitomap.org), GenBank ID: NC_012920.1. PCR was performed in a 25-µl reaction containing 50 ng DNA, PCR buffer, 1.5 mM MgCl2, 0.2 mM of each dNTP, 0.3 µM of each primer and 1.25 U Taq DNA polymerase. The reaction was performed with an initial denaturation step at 95°C for 5 min, followed by 30 cycles at 95°C for 30 sec, at 55°C for 30 sec and at 72°C for 45 sec, with a final elongation step at 72°C for 4 min.

The haplogroups of mtDNA were determined using phylogenetic analysis based on the mitochondrial phylogenetic tree as updated by van Oven and Kayser (5). The classification details were previously described by Fan and Yao (6).

 mtDNA copy number assay

The mtDNA copy number assay was previously described in detail (7). The ratio between the multi-copy mtDNA ND1 gene and the double-copy nuclear gene hemoglobin β was determined using an Applied Biosystems 7900HT Sequence Detection system (Applied Biosystems, Foster City, CA, USA). The mitochondrial ND1 and the nuclear hemoglobin β genes were individually amplified, using the ND1-forward (F)/ND1-reverse (R) and globin-F/globin-R primers, respectively. The primer pair for the mitochondrial ND1 gene was: ND1-F, 5′-ATTCGATGTTGAAGCCTGAGACT-3′; and ND1-R, 5′-TGACCCTTGGCCATAATATGATT-3′. The primer pair for the globin gene was: globin-F, 5′-ACCTCAAGGGCACCTTTGC-3′; and globin-R, 5′-AAAACATCAAGCGTCCCATAGAC-3′.

The PCR reaction mixture (15 µl) contained 0.5 ng DNA, 1X SYBR-Green master mix (Applied Biosystems) and 300 nmol of each primer. The PCR amplification consisted of a single denaturation-enzyme activation step for 8 min at 95°C, followed by 50 amplification cycles of 10 sec at 95°C, 10 sec at 60°C and 6 sec at 72°C. The data were analyzed using LightCycler software, version 3.5.3 (Roche Diagnostics, Mannheim, Germany). The ratio of mtDNA copy number to nuclear DNA was used as a measurement of mtDNA content in each specimen. All the samples were examined in triplicate and the average value was used for the ratio calculations. The R2 for each standard curve was ≥0.99. Standard deviations for the cycle of threshold (Ct) value were accepted at 0.25. The relative mtDNA copy number was calculated by a comparative Ct method, using the following equation: relative copy number (mtDNA/nDNA) = 2ΔCt (ΔCt = Ctβ-globin - CtND1). High reproducibility was observed with this assay, with a coefficient of variance of 8% (8).

 Statistical analysis

Statistical analyses were performed by Statistical Product and Service Solutions software, version 15.0 (SPSS, Inc., Chicago, IL, USA). The Student's t-test and the Chi-square test were used to compare the distributions of demographics and clinical characteristics between the gastric cancer and control groups. Wilcoxon's non-parametric and ANOVA tests were used to evaluate the differences among controls in relation to selected characteristics. For samples with normal distribution, the Student's t-test was used; for samples with non-normal distribution, comparisons were performed with Wilcoxon's non-parametric tests.

 Results <sec> <title>Patient characteristics

The main clinical characteristics of Tibetan patients with gastric cancer and control subjects are summarized in Table I. There were no significant differences between the two groups in any of the investigated characteristics. The age at diagnosis of gastric cancer was 56.3±9.1 years. Two prominent clinical characteristics were observed. A total of 56.5% of the study participants had used alcohol at some point in their lives and 73.9% were positive for H. pylori.

 mtDNA mutations

Eight mutations in 8 mitochondrial genes were identified in 10 gastric cancer patients (43.4%). Missense mutations were common. Of these 8 mutations, 7 were previously reported in other diseases; the other was a novel mutation, 8686 T>C in the ATP6 gene (Table II).

The leukocyte mtDNA copy number was 1.277±0.472 and 1.165±0.567 in Tibetan gastric cancer patients and controls, respectively. The difference between the two groups was not statistically significant (Table I). In addition, there was no significant difference in leukocyte mtDNA copy number levels by smoking status, alchohol consumption, obesity or H. pylori infection between the patient and control groups. The same findings were obtained when comparing gastric cancer patients with to those without mtDNA mutations (P>0.05; Fig. 1). Detailed information is provided in Table III.

The mtDNA D-loop sequences were analyzed based on the Revised Cambridge Reference Sequence criteria. The 23 Tibetan gastric cancer patients were classified (GenBank ID: NC_012920.1) in 5 haplogroups as follows: haplogroup M9, 8 patients; M13, 6 patients; C, 4 patients; D, 3 patients; and M7, 2 patients.

 Discussion

Tibetans have lived in a significantly cold climate combined with hypoxia for several generations. A higher incidence of gastric cancer among Tibetans was observed in high-altitude areas; therefore, a potential mechanism linking the adaptations enabling Tibetans to survive at high altitudes and gastric cancer was suspected. mtDNA is essential for the biogenesis, maintenance and bioenergetic metabolism of mitochondria. Oxidative phosphorylation damage has been proposed to play an important role in the altered energy metabolism in a number of cancer types. mtDNA is extremely susceptible to mutations due to the high levels of ROS generated in the mitochondrion. Previous studies revealed a number of tumor-specific mtDNA mutations. Wu et al (16) reported that 48% of the gastric cancer cases investigated harbored mtDNA control region tumor-specific mtDNA mutations. Mutations in the 12S rRNA gene and the tRNAPhe gene have been identified in gastric cancer (17). It was previously reported that 51% of bladder, head and neck and lung cancers harbored tumor-specific mtDNA mutations (18). However, little is known regarding Tibetan gastric cancer patients residing in a high-altitude area. In the present study, the mtDNA of gastric cancer was analyzed in Qinghai Tibetans.

Eight point mutations in encoding regions of mtDNA were detected in 43.4% (10/23) of Tibetan patients. Missense mutations were common. The 15983 T>C mutation in the tRNA-pro gene, the 15767 C>G in the CYB gene and the 7080 T>C in the COI gene were previously reported in studies on pancreatic and head and neck cancer (10,11,15). Four additional mutations, namely the 3644 T>C in the ND1 gene, the 960 insC in the 12S rRNA gene, the 15497 G>A in the CYB gene and the 11253 T>C in the ND4 gene, were previously found in obesity, deafness and bipolar disorders (9,19). The 8686 T>C mutation in the ATP6 gene was detected as a novel mutation that changes a polar serine into a hydrophobic proline in a highly conserved region of the protein. The percentage of somatic point mutations in gastric cancer (43.4%) was lower compared to that previously reported (20). This discrepancy may result from differences in race or geographic area.

The somatic mtDNA mutations detected in this study exhibited a wide spectrum, which may provide some information on Tibetan gastric cancer patients. However, a limitation of this study was the small patient sample. In addition, several mtDNA mutations found in Tibetan subjects in this study were also found as sequence variants in a population database (21). The possible reason for this may be that gastric cancer cells are prone to acquire some of the same functional mtDNA mutations as they migrate into different environments. As reported by Brandon et al (21), the adaptive mtDNA mutations may enable tumor cells to thrive in different environments as they metastasize.

Since mtDNA is exclusively maternally inherited and lacks recombination capability, there is sequential accumulation of mtDNA mutations along radiating female lineages. The sequence variants linked to adaptive mutations are also enriched. As a result, mtDNA is used in population genetics. Haplogroup association studies have been used to assess the role of mtDNA variants in various complex diseases. Therefore, the mitochondrial haplogroups of Tibetan gastric cancer patients were analyzed. A total of 23 Tibetans with gastric cancer were classified in 5 different haplogroups, namely M9, M13, C, D and M7. A total of 34.7% (8/23) patients were classified into haplogroup M9. The high frequency of haplogroup M9 in Tibetan patients is in agreement with the findings reported by Gu et al (22). It is well known that the origin and development of races and nationalities are particularly complicated. The findings from the present study may provide information on Tibetan migration patterns and cancer etiology.

The leukocyte mtDNA copy number has been investigated in several types of cancer (7,23,24). Several studies observed that a higher cancer risk is likely accompanied by an increase in the mtDNA copy number (21). The association between a lower mtDNA content and renal cell cancer risk was previously reported (7). The present study demonstrated that leukocyte mtDNA copy numbers were not statistically different between Tibetans with stage II gastric cancer and matched controls, a finding which is in agreement with the findings of a previous retrospective study (8). Considering the lack of association between mtDNA mutations and mtDNA copy number, we performed further copy number comparisons between Tibetan patients harboring mtDNA mutations and those without mutations. There were no significant differences between the two groups, which may be explained as follows: First, the comparisons may have been limited by the small sample. Second, the Tibetan population residing at high altitudes is well adapted to the hypoxic environment; however, the genetic mechanisms of long-term survival in this environmental extreme remain unclear. Better mitochondrial compensatory or adaptive functions may contribute to the indistinctive alteration of mtDNA copy numbers, particularly in early-stage cancer. The mtDNA mutations and copy numbers may be selective influences on Tibetans and are active on cells undergoing neoplastic transformation (21). However, mtDNA mutations possibly occur prior to mitochondrial copy number alterations in Tibetans with stage II gastric cancer. In conclusion, 43.4% of the gastric cancers cases in this study among Tibetans residing at high altitudes carried mtDNA mutations, although the leukocyte mtDNA copy number may not change in early-stage cancer. A larger sample size is required in order to elucidate the mechanisms underlying the development of gastric cancer in Tibetans.

 Acknowledgements

This study was supported by a grant from the Qinghai University Science Foundation (no. 2011-QYY-4) and the National Nature Sciense Foundation of China (no. 31160219).

 References AhnHSYookJHParkCHGeneral perioperative management of gastric cancer patients at high-volume centersGastric Cancer14178182201110.1007/s10120-011-0012-x21373856 MalekzadehRDerakhshanMHMalekzadehZGastric cancer in Iran: epidemiology and risk factorsArch Iran Med12576583200919877751 HungWYWuCWYinPHSomatic mutations in mitochondrial genome and their potential roles in the progression of human gastric cancerBiochim Biophys Acta1800264270201010.1016/j.bbagen.2009.06.00619527772 EdgeSBByrdDRComptonCCFritzAGGreeneFLTrottiAAJCC Cancer Staging Manual7thSpringerNew York, NY2010 van OvenMKayserMUpdated comprehensive phylogenetic tree of global human mitochondrial DNA variationHum Mutat30E386E394200910.1002/humu.2092118853457 FanLYaoYGAn update to MitoTool: using a new scoring system for faster mtDNA haplogroup determinationMitochondrion13360363201310.1016/j.mito.2013.04.01123632257 XingJChenMWoodCGMitochondrial DNA content: its genetic heritability and association with renal cell carcinomaJ Natl Cancer Inst10011041112200810.1093/jnci/djn21318664653 LiaoLMBaccarelliAShuXOMitochondrial DNA copy number and risk of gastric cancer: a report from the Shanghai Women's Health StudyCancer Epidemiol Biomarkers Prev2019441949201110.1158/1055-9965.EPI-11-037921784958 MunakataKTanakaMMoriKWashizukaSMitochondrial DNA 3644T→C mutation associated with bipolar disorderGenomics8410411050200410.1016/j.ygeno.2004.08.01515533721 JonesJBSongJJHempenPMParmigianiGHrubanRHKernSEDetection of mitochondrial DNA mutations in pancreatic cancer offers a ‘mass’-ive advantage over detection of nuclear DNA mutationsCancer Res6112991304200111245424 PorcelliAMGhelliACeccarelliCThe genetic and metabolic signature of oncocytic transformation implicates HIF1alpha destabilizationHum Mol Genet1910191032201010.1093/hmg/ddp56620028790 ElstnerMSchmidtCZinglerVCMitochondrial 12S rRNA susceptibility mutations in aminoglycoside-associated and idiopathic bilateral vestibulopathyBiochem Biophys Res Commun377379383200810.1016/j.bbrc.2008.09.13418851951 OkuraTKodaMAndoFNiinoNTanakaMShimokataHAssociation of the mitochondrial DNA 15497G/A polymorphism with obesity in a middle-aged and elderly Japanese populationHum Genet113432436200310.1007/s00439-003-0983-812905068 FauserSLuberichsJBeschDLeo-KottlerBSequence analysis of the complete mitochondrial genome in patients with Leber's hereditary optic neuropathy lacking the three most common pathogenic DNA mutationsBiochem Biophys Res Commun295342347200210.1016/S0006-291X(02)00672-112150954 PetrosJABaumannAKRuiz-PesiniEmtDNA mutations increase tumorigenicity in prostate cancerProc Natl Acad Sci USA102719724200510.1073/pnas.040889410215647368 WuCWYinPHHungWYMitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancerGenes Chromosomes Cancer441928200510.1002/gcc.2021315892105 HanCBLiFZhaoYJVariations of mitochondrial D-loop region plus downstream gene 1 2S rRNA-tRNAPHE and gastric carcinomasWorld J Gastroenterol919251929200312970877 FlissMSUsadelHCaballeroOLFacile detection of mitochondrial DNA mutations in tumors and bodily fluidsScience28720172019200010.1126/science.287.5460.201710720328 PereiraLSoaresPRadivojacPLiBSamuelsDCComparing phylogeny and the predicted pathogenicity of protein variations reveals equal purifying selection across the global human mtDNA diversityAm J Hum Genet88433439201110.1016/j.ajhg.2011.03.00621457906 MaximoVSoaresPSerucaRRochaASCastroPSobrinho-SimoesMMicrosatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinomaGenes Chromosomes Cancer32136143200110.1002/gcc.117511550281 BrandonMBaldiPWallaceDCMitochondrial mutations in cancerOncogene2546474662200610.1038/sj.onc.120960716892079 GuMDongXShiLDifferences in mtDNA whole sequence between Tibetan and Han populations suggesting adaptive selection to high altitudeGene4963744201210.1016/j.gene.2011.12.01622233893 ShenJPlatekMMahasnehAAmbrosoneCBZhaoHMitochondrial copy number and risk of breast cancer: a pilot studyMitochondrion106268201010.1016/j.mito.2009.09.00419788937 ThyagarajanBWangRNelsonHBarceloHKohWPYuanJMMitochondrial DNA copy number is associated with breast cancer riskPLoS One8e65968201310.1371/journal.pone.006596823776581

Distribution of mitochondrial DNA copy number between gastric cancer patients with (left) and those without (right) mtDNA mutation. There was no statistically significant difference between the two groups (P>0.05).

Characteristics of gastric cancer patients and controls in a Tibetan population.

Characteristics Cases, no. (%) (n=23) Controls, no. (%) (n=40) P-value
Age at diagnosis, years median ± SD 56.3±9.1 55.8±9.2 0.8180
BMI, kg/m2 0.9280
  <24   6 (26.1) 12 (30.0)
  >24 and <30 10 (43.5) 15 (37.5)
  >30   7 (30.4) 13 (32.5)
Smoking 13 (56.5) 13 (32.5) 0.0622
Alcohol 13 (56.5) 19 (47.5) 0.4904
Education 0.1219
  Lower than high school 15 (65.2) 18 (55.0)
  High school or higher   8 (34.8) 22 (45.0)
Family history of gastric cancer     2 (8.7)     2 (5.0) 0.7817
H. pylori-positive 17 (73.9) 28 (70.0) 0.7406
Copy no. 1.277±0.472 1.165±0.567 0.4218

BMI, body mass index; H. pylori, Helicobacter pylori.

Mitochondrial DNA mutations detected in Tibetan patients with gastric cancer.

Author Mutation Gene Product Case no. (Refs.)
Munakata et al 3644 T>C ND1 V-A 1 (9)
Jones et al 15983 T>C tRNA-pro tRNA-pro 1 (10)
Porcelli et al 15767 C>G CYB Q-E 2 (11)
Elstner et al 960 insC 12S rRNA 12S rRNA 1 (12)
Okura et al 15497 G>A CYB G-S 1 (13)
Present study 8686 T>C ATP6 S-P 1
Fauser et al 11253 T>C ND4 I-T 2 (14)
Petros et al 7080 T>C COI F-L 1 (15)

Means of mtDNA copy numbers by selected variables among Tibetan gastric cancer patients and control subjects.

Gastric cancer cases (n=23) Controls (n=40)
Characteristics Cases mtDNA copy no. P-value Cases mtDNA copy no. P-value
BMI, kg/m2 0.8971 0.2521
  <24 6 1.445±0.429 12 1.135±0.493
  >24 and <30 10 1.3139±0.481 15 1.235±0.742
  >30 7 1.083±0.492 13 1.111±0.408
Smoking status 0.7426 0.7667
  Never 10 1.297±0.471 13 1.184±0.618
  Ever 13 1.221±0.514 27 1.126±0.460
Alchohol consumption 0.2665 0.4026
  Never 10 1.404±0.462 21 1.237±0.635
  Ever 13 1.180±0.472 19 1.084±0.484
Family history of gastric cancer 0.1483 0.4453
  No 21 1.233±0.453 38 1.181±0.573
  Yes 2 1.743±0.559   2 0.862±0.373
H. pylori infection 0.5233 0.5257
  Positive 17 1.316±0.464 28 1.203±0.613
  Negattive 6 1.169±0.520 12 1.076±0.452

mtDNA, mitochondrial DNA; BMI, body mass index; H. pylori, Helicobacter pylori.